Thomas Holm Pedersen speaks at The First Nordic Conference on Myasthenia Gravis

Living with myasthenia gravis - The first nordic conference on myasthenia gravis, 30 Sep-1 Oct

We will be participating in the first nordic conference on myasthenia gravis, ‘Living with myasthenia gravis’ hosted by the National Danish Rehabilitation Center for Neuromuscular Diseases and Muskelsvindfonden taking place in Musholm, Denmark, 30 Sep-1 Oct.

Our CEO, Thomas Holm Pedersen will be speaking on a panel titled, ‘Involvement of patient in research - Interaction between patients and professionals in clinical activities and research’.
 
For more information see here

Previous
Previous

NMD Pharma Reports Positive Top-Line Data from a Phase I/IIa Clinical Trial of NMD670 in Patients with Myasthenia Gravis

Next
Next

FDA grants Orphan Drug Designation for NMD670 for the Treatment of Myasthenia Gravis